期刊文献+

不同剂量中/长链脂肪乳对早产低出生体质量儿的疗效及安全性 被引量:5

Effects of different doses of medium and long chain fat emulsion in parenteral nutrition on weight and liver function of premature infants
暂未订购
导出
摘要 目的 评价早期应用不同剂量脂肪乳对早产/低出生体质量儿生长及肝功能的影响。方法 随机将68例早产/低出生体质量儿分为干预组38例、对照组30例,两组新生儿均在生后12-24h内给予中/长链脂肪乳 (LCT/MCT)、氨基酸、葡萄糖等治疗,辅以非营养性吸吮和微量喂养。干预组新生儿输注中/长链脂肪乳从2.0g/(kg·d) 始,以0.5g/(kg·d)递增,逐渐增至3.0g/(kg·d);对照组中长链脂肪乳从0.5g/(kg·d) 始,以0.5g/(kg·d) 递增,逐渐增至3.0g/(kg·d)。监测两组新生儿的体质量增长情况,检测比较两组新生儿入院时以及治疗7d时的血清总胆红素、直接胆红素、丙氨酸氨基转移酶、总胆固醇、三酰甘油及血糖等指标。结果 干预组新生儿恢复出生体质量时间为 (4.52±0.92)d,短于对照组的 (6.50±2.46)d,差异有统计学意义 (P〈0.05);干预组新生儿恢复出生体质量后体质量增长为 (28.73±2.52)g/d,高于对照组的 (17.63±2.25)g/d,差异也有统计学意义。两组新生儿治疗前以及治疗第7天的血清总胆红素、直接胆红素、丙氨酸氨基转移酶、总胆固醇、三酰甘油、血糖等差异均无统计学意义 (P〉0.05);但干预组新生儿血清胆红素的最高值为 (201.39±16.31) μmol/L,低于对照组的 (220.40±15.35) μmol/L,差异有统计学意义 (P〈0.05);干预组新生儿达到胆红素最高值的日龄为 (3.65±1.12)d,也小于对照组的 (4.73±1.17)d,差异也有统计学意义 (P〈0.05)。结论 早期大量应用中/长链脂肪乳有利于改善早产/低出生体质量儿的早期营养状况,缩短住院时间,临床应用安全有效。 Objective To evaluate the impact of early application of different doses of fat emulsion on the growth and liver function of premature/low birth weight infant. Methods Sixty-eight cases of premature/low birth weight infants were randomly divided into intervention group (38 cases) and the control group (30 cases). Medium and long chain fat emulsion (LCT/MCT), amino acids and glucose complemented with non-nutritive sucking and feeding were given to two groups 12-24 hours after birth. The intervention group was infused with the medium and long chain fat emulsion at 2.0 g/(kg.d) with daily increment of 0.5 g/(kg.d) up to 3.0 g/(kg.d). The control group was infused with the medium and long chain fat emulsion at 0.5 g/(kg.d) with daily increment of 0.5 g/(kgd) up to 3.0 g/(kg.d). Neonatal body weight growth was monitored. Serum total bilirubin, direct bilirubin, alanine aminotransferase, total cholesterol, triglyceridc and blood glucose were measured and compared between the two groups at admission and 7 days after treatment. Results The recovery time of the birth weight was (4.52 ± 0.92) d in the intervention group, significantly shorter than that in the control group (6.50 ± 2.46) d (P〈0.05). Daily body weight growth was (28.73 ± 2.52) g after birth weight recovery in the intervention group, significantly higher than that of the control group (17.63 ± 2.25) g. The difference before and after treatment in serum total bilimbin, direct bilirubin, alanine aminotransferase, total cholesterol, triglyceride and blood glucose were not statistically significant (P〉0.05). The highest neonatal serum bilirubin of intervention group was (201.39 ± 16.31 )μmol/L, significantly lower than that of the control group (220.40 ± 15.35) μmol/L (P〈0.05). The intervention group reached the highest bilimbin level in (3.65 ± 1.12) d, significantly shoter than the control group (4.73 ± 1.17) d (P〈0.05). Conclusions Early application of large doses of medium and long chain fat emulsion isbeneficial in improvement of early nutritional status of preterm/low birth weight infants. It can shorten the time of hospitalizationand its clinical use is safe and effective.
出处 《临床儿科杂志》 CAS CSCD 北大核心 2012年第9期824-827,共4页 Journal of Clinical Pediatrics
关键词 静脉营养 体质量 肝功能 早产儿 parenteral nutrition body weight liver function premature infant
  • 相关文献

参考文献3

二级参考文献29

  • 1新生儿胃肠道外营养常规的建议[J].中华儿科杂志,1996,34(1):51-52. 被引量:63
  • 2李文益 陈述枚.儿科学新理论和新技术[M].北京:人民卫生出版社,2000.559.
  • 3黄惠君.早产儿肠外营养的新进展[J].国外医学(儿科学分册),1997,24(1):21-23. 被引量:27
  • 4[1]Mattar CN,Chan YS,Chong YS.Breastfeeding:it's an important gift.Obstet Gynecol 2003; 102:1414
  • 5[2]Carver JD.Advances in nutritional modifications of infant formulas.Am J Clin Nutr 2003; 77:1550S-1554S
  • 6[3]Lonnerdal B.Nutritional and physiologic significance of human milk proteins.Am J Clin Nutr 2003; 77:1537S-1543S
  • 7[4]van den Berg A,van Elburg RM,Westerbeek EA,Twisk JW,Fetter WP.Glutamine-enriched enteral nutrition in verylow-birth-weight infants and effects on feeding tolerance and infectious morbidity:a randomized controlled trial.Am J Clin Nutr 2005; 81:1397-1404
  • 8[5]Aggett PJ,Agostini C,Goulet O,Hernell O,Koletzko B,Lafeber HL,Michaelsen KF,Rigo J,Weaver LT.The nutritional and safety assessment of breast milk substitutes and other dietary products for infants:a commentary by the ESPGHAN Committee on Nutrition.J Pediatr Gastroenterol Nutr 2001; 32:256-258
  • 9[6]Clandinin MT,Van Aerde JE,Merkel KL,Harris CL,Springer MA,Hansen JW,Diersen-Schade DA.Growth and development of preterm infants fed infant formulas containing docosahexaenoic acid and arachidonic acid.J Pediatr 2005; 146:461-468
  • 10[7]Ben XM,Zhou XY,Zhao WH,Yu WL,Pan W,Zhang WL,Wu SM,Van Beusekom CM,Schaafsma A.Growth and development of term infants fed with milk with long-chain polyunsaturated fatty acid supplementation.Chin Med J (Engl) 2004; 117:1268-1270

共引文献57

同被引文献63

引证文献5

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部